3-Thio-1,2,4-triazoles, novel somatostatin sst2/sst5 agonists

Bioorganic & Medicinal Chemistry Letters
2005.0

Abstract

Novel 3-thio-1,2,4-triazoles have been obtained via a solution-phase parallel synthesis strategy, affording potent non-peptidic human somatostatin receptor subtypes 2 and 5 agonists.

Knowledge Graph

Similar Paper

3-Thio-1,2,4-triazoles, novel somatostatin sst2/sst5 agonists
Bioorganic & Medicinal Chemistry Letters 2005.0
Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5
Bioorganic & Medicinal Chemistry Letters 2001.0
Novel non-peptide ligands for the somatostatin sst3 receptor
Bioorganic & Medicinal Chemistry Letters 2001.0
Nonpeptide Somatostatin Agonists with sst<sub>4</sub> Selectivity:  Synthesis and Structure−Activity Relationships of Thioureas
Journal of Medicinal Chemistry 1998.0
Identification of Potent Non-Peptide Somatostatin Antagonists with sst<sub>3</sub> Selectivity
Journal of Medicinal Chemistry 2001.0
A Novel Somatostatin Mimic with Broad Somatotropin Release Inhibitory Factor Receptor Binding and Superior Therapeutic Potential
Journal of Medicinal Chemistry 2003.0
Discovery of Iodinated Somatostatin Analogues Selective for hsst2 and hsst5 with Excellent Inhibition of Growth Hormone and Prolactin Release from Rat Pituitary Cells
Journal of Medicinal Chemistry 2005.0
Synthesis and Structure–Activity Relationship Studies of Conformationally Flexible Tetrahydroisoquinolinyl Triazole Carboxamide and Triazole Substituted Benzamide Analogues as σ<sub>2</sub>Receptor Ligands
Journal of Medicinal Chemistry 2014.0
Thyrotropin-Releasing Hormone (TRH) Analogues That Exhibit Selectivity to TRH Receptor Subtype 2
Journal of Medicinal Chemistry 2005.0
Design, synthesis and binding affinities of novel non-peptide mimics of somatostatin/sandostatin®
Bioorganic &amp; Medicinal Chemistry Letters 1996.0